[갤럭스] [사업개발팀] Senior Director BD for Professional

[갤럭스] [사업개발팀] Senior Director BD for Professional

[모집기간]

채용 시 마감

[담당업무]

-Define Galux's partnering and out-licensing strategy, including identifying which assets and platform capabilities to bring to market, when to initiate partnering processes, which partner archetypes to prioritize, and when to walk away from a deal.

-Serve as Galux's primary external face in partnering contexts, leading executive-level discussions with global pharma and biotech BD and C-suite counterparts, investor audiences, and key opinion leaders at international conferences.

-Lead high-value negotiations as primary deal lead, making real-time judgment calls on deal structure, term tradeoffs, and competitive dynamics across the table from senior pharma counterparts.

-Advise the executive team on portfolio strategy, including go/no-go decisions on partnerships, timing of out-licensing relative to value-inflection milestones, and resource-allocation tradeoffs between internal development and external collaboration.

-Create and sustain competitive tension among potential partners by managing parallel partnering processes and controlling information flow and timing strategically.

-Independently assess and interpret Galux's R&D outputs and pipeline data to form your own view on asset value, partnering readiness, and how to position scientific narratives for different audiences.

-Steward active alliances at a strategic level, ensuring partnerships deliver on milestones, escalating and resolving issues at the executive level, and protecting Galux's long-term interests across multi-year collaborations.

-Build and institutionalize Galux's BD function by establishing processes, standards, and tools that scale as the company and team grow, and by mentoring and developing junior BD team members.

[자격요건]

-Ability to evaluate whether a deal is worth pursuing, structure terms that protect Galux's interests, assess risk-reward tradeoffs in real time during negotiations, and know when to push and when to walk away.

-Commercial and scientific storytelling at the executive level, with the ability to tailor Galux's platform and pipeline narrative to different audiences and make a compelling case for partnership.

-Portfolio-level strategic thinking, with the ability to advise leadership on how partnering decisions interact with pipeline priorities, development timelines, and company-wide resource constraints.

-Gravitas and credibility to represent Galux as a peer in discussions with SVP and C-suite-level counterparts at global pharma companies.

-Alliance governance instincts, knowing how to protect Galux's position in long-term partnerships, escalate issues before they become problems, and ensure collaborations deliver sustained value.

-Comfortable establishing BD processes, infrastructure, and team culture from a relatively early stage, rather than inheriting a mature function.

-Resilience and pragmatism in a resource-constrained environment where senior leaders are expected to operate across all levels of detail when needed.

-Bachelor's degree in related life sciences disciplines.

-10+ years of experience in biopharma business development, licensing, or M&A, including 5+ years as primary deal lead responsible for structuring, negotiating, and closing transactions.

-Demonstrated track record of closed deals with measurable commercial outcomes, not just involvement but ownership of transactions from origination through execution.

-Strong scientific fluency with the ability to independently interpret preclinical and clinical data, critically evaluate asset value, and engage credibly with senior R&D counterparts at partner organizations.

-Fluent in English (written and spoken), with the ability to lead negotiations, deliver executive-level presentations, and represent Galux with authority in high-stakes partnering and investor settings.

-Established and active network of senior BD, licensing, and R&D contacts across global pharma and biotech, with the ability to leverage existing relationships to accelerate deal origination and open doors that would otherwise be inaccessible to an early-stage company.

[우대사항]

-MS or PhD in a relevant life sciences discipline, or MD.

-Familiarity with AI-driven drug discovery or computational biology platforms.

-Experience in out-licensing or platform technology partnerships specifically, not only traditional single-asset deals.

-Direct involvement in portfolio governance or pipeline prioritization decisions at a previous organization.

-Track record of building or scaling a BD team, including hiring, developing, and retaining talent.

-Korean language proficiency.

[채용공고]